← Leaderboards
Alan Diamond
University Of Illinois At Chicago
$5,594,746
Attributed
$6,175,664
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $522.6K · FY2005–17$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$6,175,664 · 7
By mechanism
R01$4,985,056 · 4
R21$1,038,277 · 2
R03$152,331 · 1
Top collaborators
- Gail S Prins4 shared
Most similar at University Of Illinois At Chicago
Same institution · by research overlap
- Alessandro Guidotti$9,589,408
- Andrei V Gudkov$19,460,065
- Ah-Ng Tony Kong$19,827,201
- Jeremy James Johnson$2,654,168
- Larisa Nonn$5,759,500
Others in their field
Top investigators on “Glutathione Peroxidase”
- Joseph Loscalzo · Brigham And Women'S Hospital$12,169,919
- Aron B. Fisher · University Of Pennsylvania$8,420,529
- Hulya Bayir · University Of Pittsburgh At Pittsburgh$7,496,306
- Raymond F. Burk · Vanderbilt University$7,263,652
- Valerian E Kagan · Wistar Institute$6,595,264
- Brent R Stockwell · Whitehead Institute For Biomedical Res$6,473,423
Research focus
Glutathione PeroxidaseSeleniumSelenoproteinMalignant NeoplasmsProteinsCancer RiskGenesGenetic PolymorphismChemopreventionTumorAnimal ModelDietary IntakeVariantIntakeDna DamageCancer PreventionAntioxidantsGenomeCellsDietAppearanceRecurrenceDesignEpithelial Cells
Grant awards (30)
The role of MnSOD allelic variations in prostate cancer etiology and outcome$407,025
R01 · FY2017 · CA · contact PI
The role of MnSOD allelic variations in prostate cancer etiology and outcome$389,176
R01 · FY2016 · CA · contact PI
The role of MnSOD allelic variations in prostate cancer etiology and outcome$107,563
R01 · FY2016 · CA · contact PI
The role of MnSOD allelic variations in prostate cancer etiology and outcome$258,072
R01 · FY2015 · CA · contact PI
Anti-oxidant enzymes and prostate cancer$173,801
R21 · FY2015 · CA · contact PI
Anti-oxidant enzymes and prostate cancer$62,023
R21 · FY2015 · CA · contact PI
Anti-oxidant enzymes and prostate cancer$28,714
R21 · FY2015 · CA · contact PI
Anti-oxidant enzymes and prostate cancer$208,539
R21 · FY2014 · CA · contact PI
Colon Cancer Prevention with Selenium$56,142
R01 · FY2013 · CA · contact PI
Colon Cancer Prevention with Selenium$316,002
R01 · FY2012 · CA · contact PI
Colon Cancer Prevention with Selenium$59,888
R01 · FY2012 · CA · contact PI
Colon Cancer Prevention with Selenium$299,481
R01 · FY2011 · CA · contact PI
Colon Cancer Prevention with Selenium$54,229
R01 · FY2011 · CA · contact PI
Colon Cancer Prevention with Selenium$308,743
R01 · FY2010 · CA · contact PI
Selenium as an adjuvant to imatinib therapy$211,950
R21 · FY2010 · CA · contact PI
Colon Cancer Prevention with Selenium$308,743
R01 · FY2009 · CA · contact PI
Selenium as an adjuvant to imatinib therapy$176,625
R21 · FY2009 · CA · contact PI
Selenium as an adjuvant to imatinib therapy$176,625
R21 · FY2008 · CA · contact PI
Selenoproteins and Prostate Cancer$272,678
R01 · FY2007 · CA · contact PI
Selenoproteins and Prostate Cancer$280,822
R01 · FY2006 · CA · contact PI
Selenoproteins and Prostate Cancer$287,580
R01 · FY2005 · CA
Selenoproteins and Prostate Cancer$287,580
R01 · FY2004 · CA
Selenium, Aminothiols, and Radiation$258,744
R01 · FY2004 · CA
Selenium, Aminothiols, and Radiation$258,744
R01 · FY2003 · CA
Selenium, Aminothiols, and Radiation$258,744
R01 · FY2002 · CA
Role of Glutathione Peroxidase in Chemoprotection$76,131
R03 · FY2002 · ES
Selenium, Aminothiols, and Radiation$254,107
R01 · FY2001 · CA
Role of Glutathione Peroxidase in Chemoprotection$76,200
R03 · FY2001 · ES
SELENIUM, AMINOTHIOLS AND RADIATION$258,189
R01 · FY2000 · CA
SELENIUM, AMINOTHIOLS AND RADIATION$2,804
R01 · FY2000 · CA